To test the hypothesis that CYP26C1 is a modifier of SHOX deficiency, we tested different concentration of shox and cyp26c1 MOs to determine subphenotypic dosages. The gene discussed is CYP26C1; the disease is hyperinsulinemic hypoglycemia, familial, 4.